# Jiafu Ji

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jiafu-ji/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,061 |
| Field | Gastric Cancer Management and Outcomes |
| h-index | 72 |
| i10-index | 342 |
| OpenAlex ID | https://openalex.org/A5079618096 |
| ORCID iD | https://orcid.org/0000-0001-6878-5543 |
| Works | 778 |

## Researcher papers

- [International network of cancer genome projects](https://scholariq.org/papers/international-network-of-cancer-genome-projects/)
- [Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer](https://scholariq.org/papers/effect-of-laparoscopic-vs-open-distal-gastrectomy-on-3-year-disease-free/)
- [Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial](https://scholariq.org/papers/perioperative-or-postoperative-adjuvant-oxaliplatin-with-s-1-versus-adjuvant/)
- [Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer](https://scholariq.org/papers/development-and-validation-of-an-individualized-nomogram-to-identify-occult/)
- [Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study](https://scholariq.org/papers/deep-learning-radiomic-nomogram-can-predict-the-number-of-lymph-node-metastasis/)
- [Laparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer](https://scholariq.org/papers/laparoscopic-vs-open-distal-gastrectomy-for-locally-advanced-gastric-cancer/)
- [<i>FGFR2</i> Gene Amplification in Gastric Cancer Predicts Sensitivity to the Selective FGFR Inhibitor AZD4547](https://scholariq.org/papers/i-fgfr2-i-gene-amplification-in-gastric-cancer-predicts-sensitivity-to-the/)
- [Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial](https://scholariq.org/papers/safety-and-antitumour-activity-of-cadonilimab-an-anti-pd-1-ctla-4-bispecific/)
- [Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients](https://scholariq.org/papers/analysis-of-pd1-pdl1-pdl2-expression-and-t-cells-infiltration-in-1014-gastric/)

## Researcher topics

- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Metastasis and carcinoma case studies](https://scholariq.org/topics/metastasis-and-carcinoma-case-studies/)
- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.